We present an algorithm based on three PCR assays for Leishmania (Viannia) species identification and assessed its performance using 70 specimens from Peruvian patients. The succession of the assayed targets can be ordered according to species prevalence. Sequential progression through the algorithm reduced the number of samples here studied by approximately 30% after each step.
Cutaneous leishmaniasis (CL) is a vector-borne disease, which affects up to 1.5 million persons annually in tropical and subtropical regions worldwide (5). In several areas of endemicity like Peru, Leishmania species identification is important because different species with various clinical phenotypes coexist (11). There, higher incidence of mucocutaneous leishmaniasis (MCL) is attributed to Leishmania (Viannia) braziliensis (4), and low-pentavalent-antimonial treatment failures are associated with Leishmania (Viannia) guyanensis infections (1). Recognized associations between species and disease outcomes (1, 10, 12) have led the WHO expert committee on the control of leishmaniasis to recommend species identification for optimal treatment and control (16).PCR identification of Leishmania (Viannia) from clinical specimens (8, 14, 15) has used different targets: mannose phosphate isomerase (mpi) (17) and cysteine proteinase B (cpb) and the 70-kDa heat shock protein (hsp70) (6, 7, 9). These targets have been used successfully on CL specimens collected by filter paper lesion impressions (FPLIs) (3).Here, we report the development of a three-step strategy of PCR-based assays for Leishmania (Viannia) species identification and assess its performance on CL FPLIs. Reductions of time and cost to obtain results in areas where leishmaniasis is endemic were the criteria on which the algorithm was evaluated.DNA isolation from cultured parasites and filter paper lesion impressions. International reference strains and cultured parasites obtained from 80 patients attending our reference center were harvested, and their DNA was extracted as previously described (13). DNAs from anonymized, FPLI specimens from 70 CL lesions collected from 57 Peruvian patients were obtained as reported previously (2, 3). Codes and geographical origins are presented in Table S1 in the supplemental material.PCR assays for species identification. Leishmania (Viannia) species were identified using three PCR targets. The mpi gene was amplified in two separate reactions (mpi Lp and mpi Lb for Leishmania [Viannia] peruviana and L. [V.] braziliensis, respectively) according to the work of Zhang et al. (17). cpb and hsp70 genes were amplified as previously reported (7, 9). Primer sequences and reaction conditions for each target are described in Table S2 in the supplemental material.
Analysis of cultured isolates and algorithm development.Eighty cultured isolates were analyzed using the three targets, of which 41 were identified as L. Table S1 in the supplemental material). Only 1 out of 80 remained unidentifiable after the three targets were assayed. Each one of the targets ident...